Impact BioMedical Inc.
IBO
$0.45
-$0.0225-4.76%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -25.01M | -24.71M | 1.17M | -4.25M | -4.64M |
| Total Depreciation and Amortization | 6.00K | 7.00K | 6.00K | 5.00K | 6.00K |
| Total Amortization of Deferred Charges | 1.12M | 1.11M | 1.11M | 1.11M | 1.11M |
| Total Other Non-Cash Items | 20.61M | 20.51M | -5.50M | 158.00K | 315.00K |
| Change in Net Operating Assets | -603.00K | -608.00K | 352.00K | 717.00K | 887.00K |
| Cash from Operations | -3.89M | -3.69M | -2.87M | -2.25M | -2.32M |
| Capital Expenditure | -- | -- | 0.00 | -1.00K | -13.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 3.00K | 2.00K | 3.00K | 2.00K | 2.00K |
| Cash from Investing | 3.00K | 2.00K | 3.00K | 1.00K | -11.00K |
| Total Debt Issued | 1.48M | 1.96M | 1.60M | 2.25M | 2.33M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.73M | 3.73M | 3.73M | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 5.20M | 5.69M | 5.33M | 2.25M | 2.33M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.32M | 2.00M | 2.47M | -1.00K | 1.00K |